1192.2 – Reduction of mitral regurgitation through tissue approximation, using transvenous/transeptal techniques (resubmission)

New MBS item.

Percutaneous reconstruction of an insufficient mitral valve, through tissue approximation using transvenous/transeptal techniques, is performed while the heart is beating, to allow better identification of the origin of mitral regurgitation (MR).

Type: Therapeutic

MR occurs when the leaflets (or flaps) of the heart’s mitral value do not close properly and leak. The mitral valve is a one-way valve that separates the left atrium (a chamber in the heart which collects blood from the lungs) from the left ventricle (a chamber in the heart which pumps blood to the rest of the body). During pumping, the leak in the mitral valve causes blood to flow backwards into the left atrium, thereby decreasing blood flow to the body. To maintain blood flow to the body and compensate for the MR, the left ventricle must pump harder. Back flow due to MR places an extra burden on the left ventricle and lungs. Eventually, this burden can cause other problems such as: stroke, sudden death, irregular heartbeat, increasing damage to the heart muscle (progressive myocardial injury); and/or the inability to maintain adequate circulation of blood (congestive heart failure).

• PASC meeting: -
• ESC meeting: 9 June 2016
• MSAC meeting: 28 July 2016

Note: for PICO confirmation, please refer to application 1192.